Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 101–200 of 1,015
Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases
Nakamura, T., Naguro, I., & Ichijo, H. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.06.010 · Cited by 523
Regulated cell death and inflammation: an auto-amplification loop causes organ failure
Linkermann, A., Stockwell, B. R., Krautwald, S., & Anders, H.-J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3743 · Cited by 522
The diverse role of RIP kinases in necroptosis and inflammation
Silke, J., Rickard, J. A., & Gerlic, M. (2015) · Nature Immunology · doi:10.1038/ni.3206 · Cited by 514
Programmed cell death and the immune system
Nagata, S., & Tanaka, M. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.153 · Cited by 512
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 512
“We previously reported that shikonin and its analogs induced cell death with characteristics of necroptosis, a basic cell death defined by Degterev et al. and further studied in depth by the same group of scientists (Degterev et al., 2005, 2008; Hitomi et al., 2008).”
BackgroundChemotherapeutic Approaches for Targeting Cell Death Pathways
Ricci, M. S., & Zong, W.-X. (2006) · The Oncologist · doi:10.1634/theoncologist.11-4-342 · Cited by 515
“Other models of cell death have been described, including caspase-independent apoptosis, necroptosis, paraptosis, pyroptosis, and slow cell death, whose morphologic and biochemical characteristics vary from current definitions of the major cell death pathways described above [10-13].”
BackgroundThe TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
“Studies using pharmacological inhibitors or liberated RIPK kinase domains have shown that both RIPK1 and RIPK3 kinase activities are necessary for necrosome formation and necroptosis (101, 132, 248).”
BackgroundHarris, P. A., Berger, S. B., Jeong, J. U., Nagilla, R., Bandyopadhyay, D., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01751 · Cited by 480
Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat
Villalpando-Rodriguez, G. E., & Gibson, S. B. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9912436 · Cited by 491
“Finally, some necroptosis inhibitors are necrostatin-1, 3, and 5 (Nec-1, Nec-3, and Nec-5, respectively); the three of them inhibit RIP1 kinase activity [112, 113].”
BackgroundCaspase 8 inhibits programmed necrosis by processing CYLD
O’Donnell, M. A., Perez-Jimenez, E., Oberst, A., Ng, A., Massoumi, R., Xavier, R., Green, D. R., & Ting, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2362 · Cited by 494
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 479
Self-citationActive MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner
Conos, S. A., Chen, K. W., De Nardo, D., Hara, H., Whitehead, L., Núñez, G., Masters, S. L., Murphy, J. M., Schroder, K., Vaux, D. L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613305114 · Cited by 485
Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture
Riegman, M., Sagie, L., Galed, C., Levin, T., Steinberg, N., Dixon, S. J., Wiesner, U., Bradbury, M. S., Niethammer, P., Zaritsky, A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0565-1 · Cited by 474
The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
Vandenabeele, P., Declercq, W., Van Herreweghe, F., & Vanden Berghe, T. (2010) · Science Signaling · doi:10.1126/scisignal.3115re4 · Cited by 482
“The protective effects of necrostatins in experimental models of neurodegenerative diseases, ischemic brain and heart injuries, and head trauma (2, 28, 68, 69) suggest that TNF produced as a consequence of cellular stress might contribute in an autocrine or a paracrine way to stimulate metabolism.”
BackgroundInfluentialTakahashi, N., Duprez, L., Grootjans, S., Cauwels, A., Nerinckx, W., DuHadaway, J. B., Goossens, V, Roelandt, R., Van Hauwermeiren, F., Libert, C., et al. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.176 · Cited by 465
“Nec-1s was equipotent to Nec-1, confirming published results.(9,10,36) The demethylated variant of Nec-1, Nec-1i, only showed minor inhibitory activity on human RIPK1 autophosphorylation at the highest concentration (100 mM) (Figure 1c), indicating a more than 100-fold lower inhibitory activity of Nec-1i as compared w…”
BackgroundMethodResultInfluentialSelf-citationApoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium
Günther, C., Neumann, H., Neurath, M. F., & Becker, C. (2013) · Gut · doi:10.1136/gutjnl-2011-301364 · Cited by 462
Linkermann, A., Bräsen, J. H., Himmerkus, N., Liu, S., Huber, T. B., Kunzendorf, U., & Krautwald, S. (2012) · Kidney International · doi:10.1038/ki.2011.450 · Cited by 461
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Xu, D., Jin, T., Zhu, H., Chen, H., Ofengeim, D., Zou, C., Mifflin, L., Pan, L., Amin, P., Li, W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.041 · Cited by 461
“The treatment of TNF-a/cycloheximide (CHX) is an established protocol to induce RIPK1-independent apoptosis (RIA) (Degterev et al., 2005; Zimmermann and Green, 2001).”
Self-citationmiR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma
Luo, M., Wu, L., Zhang, K., Wang, H., Zhang, T., Gutierrez, L., O’Connell, D., Zhang, P., Li, Y., Gao, T., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0053-8 · Cited by 408
“However, this view has been recently challenged by the discovery of several nonapoptotic cell death pathways [4– 6], including necroptosis [7] and ferroptosis [8].”
Self-citationMlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis
Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.91 · Cited by 462
Self-citationVaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
Aaes, T. L., Kaczmarek, A., Delvaeye, T., De Craene, B., De Koker, S., Heyndrickx, L., Delrue, I., Taminau, J., Wiernicki, B., De Groote, P., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.037 · Cited by 443
Necroptosis and tumor progression
Yan, J., Wan, P., Choksi, S., & Liu, Z.-G. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2021.09.003 · Cited by 445
Dying cells actively regulate adaptive immune responses
Yatim, N., Cullen, S., & Albert, M. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.9 · Cited by 442
Newton, K., Dugger, D. L., Maltzman, A., Greve, J. M., Hedehus, M., Martin-McNulty, B., Carano, R. A. D., Cao, T. C., van Bruggen, N., Bernstein, L., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.46 · Cited by 438
“Our finding that RIPK3-deficient mice are not protected in the MCAO model of stroke (Figures 3b and c) is interesting given that inhibition of RIPK1 with necrostatin-1 is reported to be protective in this model.(34) The differential sensitivity of the MCAO model to RIPK1 inhibition and RIPK3 deficiency is reminiscent…”
BackgroundThe biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death
Ai, Y., Meng, Y., Yan, B., Zhou, Q., & Wang, X. (2024) · Molecular Cell · doi:10.1016/j.molcel.2023.11.040 · Cited by 422
Robinson, N., McComb, S., Mulligan, R., Dudani, R., Krishnan, L., & Sad, S. (2012) · Nature Immunology · doi:10.1038/ni.2397 · Cited by 438
Functional complementation between FADD and RIP1 in embryos and lymphocytes
Zhang, H., Zhou, X., McQuade, T., Li, J., Chan, F. K.-M., & Zhang, J. (2011) · Nature · doi:10.1038/nature09878 · Cited by 427
RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation
Lin, J., Kumari, S., Kim, C., Van, T.-M., Wachsmuth, L., Polykratis, A., & Pasparakis, M. (2016) · Nature · doi:10.1038/nature20558 · Cited by 421
Caspase-8 Blocks Kinase RIPK3-Mediated Activation of the NLRP3 Inflammasome
Kang, T.-B., Yang, S.-H., Toth, B., Kovalenko, A., & Wallach, D. (2013) · Immunity · doi:10.1016/j.immuni.2012.09.015 · Cited by 419
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 411
Apoptosis, Pyroptosis, and Necroptosis—Oh My! The Many Ways a Cell Can Die
Ketelut-Carneiro, N., & Fitzgerald, K. A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167378 · Cited by 410
Necroptosis: a crucial pathogenic mediator of human disease
Choi, M. E., Price, D. R., Ryter, S. W., & Choi, A. M. K. (2019) · JCI Insight · doi:10.1172/jci.insight.128834 · Cited by 419
Necroptosis in health and diseases
Zhou, W., & Yuan, J. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.07.013 · Cited by 414
“On the other hand, RIP1 kinase activity is critical for necroptosis as shown by the ability of Nec-1 to potently inhibit necroptosis [7,8].”
BackgroundResultInfluentialSelf-citationSecondary necrosis: The natural outcome of the complete apoptotic program
Silva, M. T. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.046 · Cited by 421
“include apoptosis, necrosis (or necroptosis [2]), autophagic death and cornification [3].”
BackgroundGetting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV
Kim, Y., Anderson, J. L., & Lewin, S. R. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2017.12.004 · Cited by 414
“However, necrosis is not always passive and can result from a signal cascade in a regulated manner, much like apoptosis, aptly termed necroptosis (Degterev et al, 2005).”
BackgroundNeuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
Chi, H., Chang, H.-Y., & Sang, T.-K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103082 · Cited by 412
“The common perception is that some neurons, especially those in the core, will undergo uncontrolled necrosis immediately after the ischemia, ensured by other regulated forms of neuronal cell death that can be stopped [14,45,46].”
BackgroundTargeting RIPK1 for the treatment of human diseases
Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 408
“A first set of selective necroptosis inhibitors, which we termed necrostatins, was identified using a cell-based screen of TNF-induced necroptosis in a human U937 monocytic cell line (11).”
BackgroundMethodInfluentialSelf-citationMany stimuli pull the necrotic trigger, an overview
Vanlangenakker, N., Vanden Berghe, T., & Vandenabeele, P. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.164 · Cited by 407
“Interestingly, Nec-1 treatment protects against IR-injury in vivo.(14,45,46,142,143) In contrast to the requirement for RIPK1 in TNF-induced necroptosis,(13) the role of RIPK1 in H2O2-induced necrosis is controversial.”
BackgroundImmunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Meier, P., Legrand, A. J., Adam, D., & Silke, J. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00674-x · Cited by 382
“Necroptosis signalling proceeds when caspase 8 activity is low, absent or suppressed, such as in response to viral inhibitors 60,216 , pharmacological inhibition 217 and genetic or epigenetic loss 214,218 .”
Necroptosis Drives Motor Neuron Death in Models of Both Sporadic and Familial ALS
Re, D. B., Le Verche, V., Yu, C., Amoroso, M. W., Politi, K. A., Phani, S., Ikiz, B., Hoffmann, L., Koolen, M., Nagata, T., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.011 · Cited by 406
“Necroptosis has already been implicated in acute insults, such as brain ischemia (Degterev et al. 2005), but, to our knowledge, never before in a model of a neurodegenerative condition such as ALS.”
Newton, K., & Manning, G. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014830 · Cited by 402
Wang, P., Shao, B.-Z., Deng, Z., Chen, S., Yue, Z., & Miao, C.-Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.01.001 · Cited by 394
RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395
Self-citationAcetaminophen from liver to brain: New insights into drug pharmacological action and toxicity
Ghanem, C. I., Pérez, M. J., Manautou, J. E., & Mottino, A. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.020 · Cited by 384
Major cell death pathways at a glance
Duprez, L., Wirawan, E., Berghe, T. V., & Vandenabeele, P. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.08.013 · Cited by 385
“RIP1 is a crucial initiator of death receptor-mediated necrosis [21] and the term necroptosis was introduced to designate programmed necrosis that depends on RIP1 [22].”
BackgroundInfluentialNeuronal cell death in neonatal hypoxia‐ischemia
Northington, F. J., Chavez‐Valdez, R., & Martin, L. J. (2011) · Annals of Neurology · doi:10.1002/ana.22419 · Cited by 380
Cerebral Ischemia-Hypoxia Induces Intravascular Coagulation and Autophagy
Adhami, F., Liao, G., Morozov, Y. M., Schloemer, A., Schmithorst, V. J., Lorenz, J. N., Dunn, R. S., Vorhees, C. V., Wills-Karp, M., Degen, J. L., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.051066 · Cited by 326
Self-citationCell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options
Sekerdag, E., Solaroglu, I., & Gursoy-Ozdemir, Y. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302115544 · Cited by 369
“In general, death receptors mediate apoptosis, however these death receptors can also activate necrotic cell death [87].”
BackgroundProgrammed necrotic cell death of macrophages: Focus on pyroptosis, necroptosis, and parthanatos
Robinson, N., Ganesan, R., Hegedűs, C., Kovács, K., Kufer, T. A., & Virág, L. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101239 · Cited by 368
“The pathway leading to necroptosis has been largely deciphered through the discovery of small molecule inhibitors that block RIPK1 (necrostatin-1) [52], RIPK3 (GSK′872) [53], and MLKL (necrosulfonamide) [49].”
BackgroundCell Death in the Origin and Treatment of Cancer
Strasser, A., & Vaux, D. L. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.014 · Cited by 370
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
Die another way – non-apoptotic mechanisms of cell death
Tait, S. W. G., Ichim, G., & Green, D. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.093575 · Cited by 366
“Necroptosis Various stimuli can engage a non-apoptotic form of cell death called necroptosis (Degterev et al., 2005).”
BackgroundCaspase-independent cell death: leaving the set without the final cut
Tait, S. W. G., & Green, D. R. (2008) · Oncogene · doi:10.1038/onc.2008.311 · Cited by 352
“Here, we use the term necroptosis to describe CICD induced by death receptors to distinguish this from MOMP-induced CICD, as the mechanisms of death are almost certainly distinct (Degterev et al., 2005).”
MethodProgrammed necrosis: backup to and competitor with apoptosis in the immune system
Han, J., Zhong, C.-Q., & Zhang, D.-W. (2011) · Nature Immunology · doi:10.1038/ni.2159 · Cited by 367
“However, growing evidence has unambiguously demonstrated that certain types of necrosis are tightly controlled by orchestrated intrinsic cellular programs and are now called necroptosi”
BackgroundShikonin circumvents cancer drug resistance by induction of a necroptotic death
Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J., & Hu, X. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0511 · Cited by 364
“icities toward the known cell death pathways and effects on cellular and molecular biology of cells (19).”
BackgroundInfluentialPyroptosis in health and disease: mechanisms, regulation and clinical perspective
Liu, Y., Pan, R., Ouyang, Y., Gu, W., Xiao, T., Yang, H., Tang, L., Wang, H., Xiang, B., & Chen, P. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01958-2 · Cited by 337
Regulated necrosis in kidney ischemia-reperfusion injury
Pefanis, A., Ierino, F. L., Murphy, J. M., & Cowan, P. J. (2019) · Kidney International · doi:10.1016/j.kint.2019.02.009 · Cited by 361
Samson, A. L., Zhang, Y., Geoghegan, N. D., Gavin, X. J., Davies, K. A., Mlodzianoski, M. J., Whitehead, L. W., Frank, D., Garnish, S. E., Fitzgibbon, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16887-1 · Cited by 362
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., Takahashi, N., Sergent, O., Lagadic-Gossmann, D., Vandenabeele, P., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.90 · Cited by 357
Identification and Successful Negotiation of a Metabolic Checkpoint in Direct Neuronal Reprogramming
Gascón, S., Murenu, E., Masserdotti, G., Ortega, F., Russo, G. L., Petrik, D., Deshpande, A., Heinrich, C., Karow, M., Robertson, S. P., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.12.003 · Cited by 360
“hibitors Necrostatin-1 (Degterev et al., 2005) and Liproxstatin-1 (Friedmann Angeli et al.”
BackgroundMethodFerroptosis in health and disease
Berndt, C., Alborzinia, H., Amen, V. S., Ayton, S., Barayeu, U., Bartelt, A., Bayir, H., Bebber, C. M., Birsoy, K., Böttcher, J. P., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103211 · Cited by 334
RIP3: a molecular switch for necrosis and inflammation
Moriwaki, K., & Chan, F. K.-M. (2013) · Genes & Development · doi:10.1101/gad.223321.113 · Cited by 355
“Research on necrosis got a significant boost when necrostatins, a class of chemical inhibitors of RIP1, became available (Degterev et al. 2005, 2008).”
BackgroundZhang, Y., Zhan, X., Xiong, J., Peng, S., Huang, W., Joshi, R., Cai, Y., Liu, Y., Li, R., Yuan, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26978-1 · Cited by 348
Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications
Zheng, Y., Sun, J., Luo, Z., Li, Y., & Huang, Y. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07244-x · Cited by 320
“Brie fl y, when either caspase 8 or fas-associated via death domain (FADD) is depleted or the function is inhibited, TNF can induce caspase 8 independent necrosis through activating RIPK1 (receptor interacting serine/threonine kinase 1) [94].”
Self-citationThe independence of and associations among apoptosis, autophagy, and necrosis
Chen, Q., Kang, J., & Fu, C. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0018-5 · Cited by 346
Noncanonical autophagy promotes the visual cycle
Kim, J.-Y., Zhao, H., Martinez, J., Doggett, T. A., Kolesnikov, A. V., Tang, P. H., Ablonczy, Z., Chan, C.-C., Zhou, Z., Green, D. R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.012 · Cited by 347
“Constitutive autophagy has been shown to function as a cellrepair mechanism that is particularly important for long-lived postmitotic cells (Degterev et al., 2005; Komatsu et al., 2006; Nishiyama et al., 2007) (Hartleben et al., 2010).”
Identification of Aneuploidy-Selective Antiproliferation Compounds
Tang, Y.-C., Williams, B. R., Siegel, J. J., & Amon, A. (2011) · Cell · doi:10.1016/j.cell.2011.01.017 · Cited by 328
“Treatment of cells with necrostatin-1 (Nec-1), an inhibitor for necroptosis (Degterev et al., 2005), did not suppress the antiproliferative effects of AICAR either (Figure S2C).”
Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 343
“Necrostatin-1 can inhibit all published examples of necrotic cell death induced by activation of death domain receptors in the presence of caspase inhibitors (Degterev et al., 2005).”
BackgroundNecroptosis in development and diseases
Shan, B., Pan, H., Najafov, A., & Yuan, J. (2018) · Genes & Development · doi:10.1101/gad.312561.118 · Cited by 347
“Necroptosis was first defined by its inhibition with specific chemical inhibitors of RIPK1, such as necrostatin-1 (Nec-1) and its improved analog, Nec-1s (Degterev et al. 2005, 2008).”
BackgroundInfluentialSelf-citationMicroRNAs in apoptosis, autophagy and necroptosis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.3523 · Cited by 342
“Necroptosis can be pharmacologically inhibited using certain chemical compounds such as necrostatin-1 [126].”
BackgroundCell death in pancreatic cancer: from pathogenesis to therapy
Chen, X., Zeh, H. J., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00486-6 · Cited by 336
Vanlangenakker, N., Vanden Berghe, T., Bogaert, P., Laukens, B., Zobel, K., Deshayes, K., Vucic, D., Fulda, S., Vandenabeele, P., & Bertrand, M. J. M. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.138 · Cited by 339
“The identification of the RIP1 kinase inhibitor Nec-1 has enabled researchers to reveal the involvement of necrotic cell death in an increasing number of pathological conditions.(3,4) Indeed, RIP1 kinase activity is dispensable in most apoptotic conditions, but is crucial for the activation of a regulated form of necr…”
BackgroundFerroptosis and cell death mechanisms in Parkinson's disease
Guiney, S. J., Adlard, P. A., Bush, A. I., Finkelstein, D. I., & Ayton, S. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.004 · Cited by 338
“disruption and loss of autophagic clearance of cellular debris (Degterev et al., 2005).”
The Structure of the Necrosome RIPK1-RIPK3 Core, a Human Hetero-Amyloid Signaling Complex
Mompeán, M., Li, W., Li, J., Laage, S., Siemer, A. B., Bozkurt, G., Wu, H., & McDermott, A. E. (2018) · Cell · doi:10.1016/j.cell.2018.03.032 · Cited by 336
“The discovery of small-molecule compounds (necrostatins) that block necroptotic cell death in vitro and in vivo (Degterev et al., 2005) opened new avenues to target necroptosis in pathological scenarios, such as viral infection or neurodegenerative diseases (Vandenabeele et al.”
The therapeutic potential of targeting regulated non-apoptotic cell death
Hadian, K., & Stockwell, B. R. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00749-8 · Cited by 320
He, X., Li, Y., Deng, B., Lin, A., Zhang, G., Ma, M., Wang, Y., Yang, Y., & Kang, X. (2022) · Cell Proliferation · doi:10.1111/cpr.13275 · Cited by 326
“In recent years, a new type of cell death has been discovered, with characteristics similar to necrosis: this process, necroptosis or regulated necrosis, is triggered by the binding of death ligand to the death receptor.(92) During necroptosis, a complex is formed that comprises TNFR-associated death domain, FASassoci…”
BackgroundSelf-citationCell death pathways: intricate connections and disease implications
Kist, M., & Vucic, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106700 · Cited by 321
“Soon, it became obvious that caspase-8 has a more complex role, especially in the regulation of other cell death pathways (Degterev et al , 2005) Caspase-8 lethality can be rescued by deletion of RIP3 or MLKL (Kaiser et al , 2011; Oberst et al , 2011), which indicated that caspase-8 restricts…”
Necrostatin: A Potentially Novel Cardioprotective Agent?
Smith, C. C. T., Davidson, S. M., Lim, S. Y., Simpkin, J. C., Hothersall, J. S., & Yellon, D. M. (2007) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-007-6035-1 · Cited by 326
Oerlemans, M. I. F. J., Liu, J., Arslan, F., Ouden, K., Middelaar, B. J., Doevendans, P. A., & Sluijter, J. P. G. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0270-8 · Cited by 328
“cytes, endothelial cells (data not shown), neuronal cells and other cardiac-derived lineages in vitro under oxidative stress [8, 24, 36], We investigated the effect of a single dose of Nec-1 given at reperfusion, which is an important prerequisite for future clinical translation [10].”
Necroptosis in the Pathophysiology of Disease
Khoury, M. K., Gupta, K., Franco, S. R., & Liu, B. (2020) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.10.012 · Cited by 323
Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00406-w · Cited by 325
Self-citationMitochondrial permeability transition pore is a potential drug target for neurodegeneration
Rao, V. K., Carlson, E. A., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.003 · Cited by 324
Programmed Cell Death Tunes Tumor Immunity
Liu, J., Hong, M., Li, Y., Chen, D., Wu, Y., & Hu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847345 · Cited by 316
Self-citationWang, H., Feng, Z., Wang, Y., Zhou, R., Yang, Z., & Xu, B. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09783 · Cited by 315
Bonapace, L., Bornhauser, B. C., Schmitz, M., Cario, G., Ziegler, U., Niggli, F. K., Schäfer, B. W., Schrappe, M., Stanulla, M., & Bourquin, J.-P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39987 · Cited by 312
“In this context, activation of autophagy is required to induce necroptosis, a form of programmed necrosis that has been described to occur when apoptosis is abortive due to caspase inhibition (16, 56).”
BackgroundResultTherapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes
Pandeya, A., & Kanneganti, T.-D. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.10.001 · Cited by 303
Trichonas, G., Murakami, Y., Thanos, A., Morizane, Y., Kayama, M., Debouck, C. M., Hisatomi, T., Miller, J. W., & Vavvas, D. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009179107 · Cited by 312
“This unique mechanism of cell death is termed programmed necrosis or necroptosis (11).”
BackgroundNecroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators
Seo, J., Nam, Y. W., Kim, S., Oh, D.-B., & Song, J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00634-7 · Cited by 312
Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or Necrosis
Iorga, A., Dara, L., & Kaplowitz, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051018 · Cited by 268
“Necroptosis requires the kinase activity of RIPK1 and is inhibited by the necrostatins (nec) which are RIPK1 kinase inhibitors [35,39].”
BackgroundProgrammed cell death in spinal cord injury pathogenesis and therapy
Shi, Z., Yuan, S., Shi, L., Li, J., Ning, G., Kong, X., & Feng, S. (2021) · Cell Proliferation · doi:10.1111/cpr.12992 · Cited by 293
Mihaly, S. R., Ninomiya-Tsuji, J., & Morioka, S. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.123 · Cited by 288
“TAK1 may also be potentially hyperactivated when caspase is exogenously inhibited by viral infection or under yet unidentified conditions, which could be associated with pathologic necroptotic conditions such as ischemic tissue injuries and systemic inflammation.(90,91)”
BackgroundTargeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis
Karunakaran, D., Geoffrion, M., Wei, L., Gan, W., Richards, L., Shangari, P., DeKemp, E. M., Beanlands, R. A., Perisic, L., Maegdefessel, L., et al. (2016) · Science Advances · doi:10.1126/sciadv.1600224 · Cited by 293
Programmed cell death and its role in inflammation
Yang, Y., Jiang, G., Zhang, P., & Fan, J. (2015) · Military Medical Research · doi:10.1186/s40779-015-0039-0 · Cited by 290
“Recent studies using genetic approaches [4–7] and chemical inhibitors of necrosis [4, 8, 9] demonstrated the existence of multiple pathways of regulated necrosis.”
BackgroundKarch, J., Kwong, J. Q., Burr, A. R., Sargent, M. A., Elrod, J. W., Peixoto, P. M., Martinez-Caballero, S., Osinska, H., Cheng, E. H.-Y., Robbins, J., et al. (2013) · eLife · doi:10.7554/elife.00772 · Cited by 290
“Necroptosis is induced in cells when stimulated with tumor necrosis factor α (TNFα) in the presence of caspase inhibitors, such as zVAD-fmk (Degterev et al., 2005).”
BackgroundFADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells
Bell, B. D., Leverrier, S., Weist, B. M., Newton, R. H., Arechiga, A. F., Luhrs, K. A., Morrissette, N. S., & Walsh, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808597105 · Cited by 295
“Nec-1 also dose-dependently restored live cell recovery (Fig.”
BackgroundInfluentialProgrammed Necrosis, Not Apoptosis, in the Heart
Kung, G., Konstantinidis, K., & Kitsis, R. N. (2011) · Circulation Research · doi:10.1161/circresaha.110.225730 · Cited by 291
Roles of Caspases in Necrotic Cell Death
Yuan, J., Najafov, A., & Py, B. F. (2016) · Cell · doi:10.1016/j.cell.2016.11.047 · Cited by 293
Self-citationProgramming inflammatory cell death for therapy
Christgen, S., Tweedell, R. E., & Kanneganti, T.-D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108010 · Cited by 288
Which cell death modality wins the contest for photodynamic therapy of cancer?
Mishchenko, T., Balalaeva, I., Gorokhova, A., Vedunova, M., & Krysko, D. V. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-04851-4 · Cited by 276
Alternative cell death mechanisms in development and beyond
Yuan, J., & Kroemer, G. (2010) · Genes & Development · doi:10.1101/gad.1984410 · Cited by 290
“Importantly, a small molecule inhibitor of necroptosis, necrostatin-1 (Nec-1), is a potent inhibitor of RIP1 kinase activity and necroptosis (Degterev et al. 2008).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.